跳至主要内容
临床试验/NCT06146309
NCT06146309已完成不适用

Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
peri-papillary retinal nerve fiber layer thickness

研究概览

简要总结

Several studies have indicated a relation between the development of RVO and elevated intraocular pressure (IOP) and glaucoma [9]. Further investigations into the structural alterations in the fellow eyes of individuals with unilateral RVO have revealed that the pRNFL is thinner than in healthy eyes, suggesting that there may be systemic risk factors for both RVO and glaucoma

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
47 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with unilateral BRVO

排除标准

  • History of retinal and/or optic nerve diseases involving glaucomatous optic disc, ischemic optic neuropathy, or optic neuritis.
  • History of trauma, intravitreal injections, vitreoretinal surgeries, and retinal or macular lasers.
  • A significant media opacity that makes it difficult to capture clear images.
  • No history of diabetes and/or hypertension in those recruited as the control group

研究组 & 干预措施

Patients with unilateral BRVO

Experimental

干预措施: aflibercept (2mg/0.05ml) (Drug)

结局指标

主要结局

peri-papillary retinal nerve fiber layer thickness

时间窗: 24 months post injection

Layer of the retina. The thickness was measured by Optical Coherence Tomography

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Akram Fekry Elgazzar

Principal Investigator

Al-Azhar University

研究点 (1)

Loading locations...

相似试验

Assessment Of Peri-papillary Retinal Nerve Fiber... | 临床试验